Developmental Dysplasia of Hip
Conditions
Interventions
experimental group:THA through DAA
control cohort:THA through PLA
Sponsors
The Second Affiliated Hospital of Army Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years, gender unlimited. 2. Patients diagnosed with unilateral or bilateral secondary osteoarthritis of the hip, Crowe Type III-IV Developmental Dysplasia of the Hip. 3. Unilateral or one-stage bilateral total hip arthroplasty (including direct anterior and posterolateral approaches). 4. Subjects fully understand the benefits and risks of this study, and are willing to participate and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1.Bilateral DDH but treated with unilateral THA. 2.Possible infection around hip. 3.Severe contracture of the hip caused by previous surgery. 4.DDH combined with a neurovascular disease and poliomyelitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Harris Hip Score;Post-operative complications; | — |
Secondary
| Measure | Time frame |
|---|---|
| leg length discrepancy (LLD);hip abductor and flexor strength;limp;Short-Form 12-item Health Survey;Western Ontario and McMaster Universities Osteoarthritis Index; | — |
Countries
China
Contacts
Public ContactZhang Yuan
Department of Orthopedics, The Second Affiliated Hospital of Army Medical University
Outcome results
None listed